The thesis of Bart Heeg deals with health-economic modelling of chronic diseases for reimbursement purposes. With an ageing population the number of chronic diseases, often requiring chronic treatment, is increasing. New health care technologies, such as drugs, diagnostics and medical devices, often provide an improvement to current standard of care. This improvement obviously comes at a certain cost. In health economics, this added benefit is weighted against the higher costs to determine whether a technology is cost-effective and in the end should be reimbursed. For that purpose, health economic models are used. In the first part, various modelling approaches are discussed and applications of those approaches presented for three chronic diseases (schizophrenia, cardiovascular disease and multiple myeloma). The second part is on model parameter estimations in terms of (i) incorporating compliance and (ii) various methods of incorporating categorical inputs in health economic models. Finally, the issue of identifying variables (including health economic outcomes), that are predictive for reimbursement decisions in Scotland, is addressed.
B.M.S. Heeg, MSc
May 01, 2015
prof. dr. M.J. (Maarten) Postma
, B.A. Hout,
prof. dr. E. (Erik) Buskens
Academy building RUG
Mathematics and Natural Sciences
Many major Dutch companies publish extensive information about climate impact in their annual reports. However, very few companies provide concrete, detailed information about their own CO2 emissions, the impact of climate change on their business...
The University of Groningen (UG) has permanently closed the project aimed at creating a branch campus in Yantai. Discussions were held with China Agricultural University, the city of Yantai and the Province of Shandong.
Offers of cheap single train tickets through retailers such as Kruidvat or Etos have a positive impact on the number of kilometres travelled by rail. This impact is much bigger than that of more general TV, newspaper or magazine advertising. However,...